ストックスクリーナーアプリを入手
3.09
4.45%
-0.17
前日終値:
$3.26
開ける：
$3.3
24時間の取引高:
233.43K
Relative Volume:
0.09
時価総額：
$149.75M
収益：
-
当期純損益:
$-97.22M
株価収益率:
-2.2391
EPS:
-1.38
ネットキャッシュフロー:
$-82.44M
1週間 パフォーマンス:
-18.03%
1か月 パフォーマンス:
-14.19%
6か月 パフォーマンス:
+93.48%
1年 パフォーマンス:
-88.12%
1日の値動き範囲:
$3.0901
$3.32
1週間の範囲:
$3.11
$3.81
52週間の値動き範囲:
$1.15
$33.98
Cassava Sciences Inc Stock (SAVA) Company Profile
名前
Cassava Sciences Inc
セクター
電話
512-501-2444
住所
6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX
SAVA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SAVA
Cassava Sciences Inc
|
3.10 | 157.48M | 0 | -97.22M | -82.44M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.52 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
635.18 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.68 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
827.86 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.35 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cassava Sciences Inc Stock (SAVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-26 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-10-08 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2024-07-01 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2022-11-16 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2021-07-15 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2021-07-07 | 繰り返されました | Maxim Group | Buy |
| 2021-04-27 | 開始されました | B. Riley Securities | Buy |
| 2021-02-16 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-10-23 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-09-23 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-05-18 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2020-05-15 | ダウングレード | Maxim Group | Buy → Hold |
| 2020-01-10 | 繰り返されました | Maxim Group | Buy |
すべてを表示
Cassava Sciences Inc (SAVA) 最新ニュース
What risks investors should watch in Cassava Sciences Inc. stockJuly 2025 Opening Moves & Weekly High Return Stock Forecasts - newser.com
Is Cassava Sciences Inc. stock a buy on dipsGDP Growth & Weekly Market Pulse Alerts - newser.com
Can Cassava Sciences Inc. stock attract ESG capital inflowsEarnings Beat & Stock Portfolio Risk Control - newser.com
Is it too late to sell Cassava Sciences Inc.Weekly Trend Recap & Reliable Price Breakout Signals - newser.com
Tools to monitor Cassava Sciences Inc. Equity Warrant recovery probabilityTrade Risk Report & Daily Stock Trend Reports - newser.com
Full technical analysis of Cassava Sciences Inc. stockEarnings Miss & Advanced Technical Signal Analysis - newser.com
Why analysts upgrade Cassava Sciences Inc. stock2025 Trade Ideas & Reliable Intraday Trade Alerts - newser.com
Is Cassava Sciences Inc. Equity Warrant stock affected by interest rate hikesAnalyst Downgrade & Stepwise Entry and Exit Trade Signals - newser.com
Will Cassava Sciences Inc. continue its uptrendEarnings Recap Summary & Proven Capital Preservation Methods - newser.com
Will Cassava Sciences Inc. Equity Warrant stock benefit from sector rotationM&A Rumor & Verified Swing Trading Watchlists - newser.com
Why Cassava Sciences Inc. Equity Warrant stock is a value investor pickM&A Rumor & Stock Portfolio Risk Control - newser.com
Can Cassava Sciences Inc. (PX91) stock ride next bull market cycleSell Signal & Technical Analysis for Trade Confirmation - newser.com
Why Cassava Sciences Inc. (PX91) stock could be next leaderEarnings Recap Summary & AI Enhanced Trading Alerts - newser.com
Will Cassava Sciences Inc. stock go up soon2025 Risk Factors & Consistent Growth Equity Picks - newser.com
Will Cassava Sciences Inc. Equity Warrant stock keep outperforming rivalsMarket Growth Summary & Real-Time Sentiment Analysis - newser.com
How strong is Cassava Sciences Inc. stock revenue growth2025 EndofYear Setup & Safe Capital Allocation Plans - newser.com
What analysts say about Maywood Acquisition Corp stockRelative Strength Index (RSI) & Budget Friendly Trading Strategies - earlytimes.in
Risk adjusted return profile for Cassava Sciences Inc. analyzed2025 Investor Takeaways & Expert Verified Movement Alerts - newser.com
Cassava Sciences Inc. Equity Warrant stock volume spike explainedWeekly Gains Summary & High Return Trade Opportunity Guides - newser.com
Why Cassava Sciences Inc. stock is in analyst buy zoneMarket Activity Report & Safe Entry Momentum Tips - newser.com
Chart overlay techniques for tracking Cassava Sciences Inc.July 2025 WrapUp & Low Volatility Stock Suggestions - newser.com
How institutional ownership impacts Cassava Sciences Inc. Equity Warrant stockQuarterly Trade Report & Breakout Confirmation Alerts - newser.com
Can Cassava Sciences Inc. Equity Warrant stock maintain operating marginsJuly 2025 Fed Impact & AI Optimized Trading Strategy Guides - newser.com
Will Cassava Sciences Inc. (PX91) stock benefit from mergersMarket Sentiment Summary & Proven Capital Preservation Methods - newser.com
Cassava Sciences (NASDAQ:SAVA) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat
What the charts say about Cassava Sciences Inc. today2025 Trading Volume Trends & Daily Growth Stock Investment Tips - newser.com
Why Cassava Sciences Inc. is moving todayJuly 2025 Decliners & Precise Entry and Exit Recommendations - newser.com
Will Cassava Sciences Inc. Equity Warrant stock deliver shareholder valueJuly 2025 Opening Moves & Pattern Based Trade Signal System - newser.com
Cassava Sciences Inc (SAVA) 財務データ
収益
当期純利益
現金流量
EPS
Cassava Sciences Inc (SAVA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Barry Richard | President & CEO |
Sep 22 '25 |
Buy |
2.28 |
7,172 |
16,352 |
714,675 |
| Barry Richard | President & CEO |
Sep 18 '25 |
Buy |
2.24 |
190,633 |
426,424 |
660,195 |
| Barry Richard | President & CEO |
Sep 19 '25 |
Buy |
2.29 |
47,308 |
108,319 |
707,503 |
| Kupiec James William | Chief Medical Officer |
Nov 29 '24 |
Sale |
3.87 |
4,000 |
15,480 |
0 |
| Schoen Eric | Chief Financial Officer |
Nov 29 '24 |
Option Exercise |
1.18 |
50,000 |
59,000 |
71,300 |
| Schoen Eric | Chief Financial Officer |
Nov 29 '24 |
Sale |
3.86 |
59,800 |
230,828 |
11,500 |
| Schoen Eric | Chief Financial Officer |
Nov 29 '24 |
Sale |
3.82 |
2,000 |
7,640 |
0 |
0.21%
0.74%
大文字化:
|
ボリューム (24 時間):